How to probe clinical tumour samples for P-glycoprotein and multidrug resistance-associated protein.

Suppr

超能文献

作者信息

Broxterman H J, Lankelma J, Pinedo H M

机构信息

Department of Medical Oncology, Free University Hospital, Amsterdam, Netherlands.

出版信息

Eur J Cancer. 1996 Jun;32A(6):1024-33. doi: 10.1016/0959-8049(96)00045-7.

DOI:10.1016/0959-8049(96)00045-7

PMID:8763344

Abstract

摘要

相似文献

How to probe clinical tumour samples for P-glycoprotein and multidrug resistance-associated protein.

Eur J Cancer. 1996 Jun;32A(6):1024-33. doi: 10.1016/0959-8049(96)00045-7.

Molecular diagnosis of multidrug resistance.

Cancer Treat Res. 1994;73:129-47. doi: 10.1007/978-1-4615-2632-2_7.

Diagnostics of multidrug resistance in cancer.癌症多药耐药性的诊断

Pathol Oncol Res. 1998;4(4):251-7. doi: 10.1007/BF02905214.

Optimal immunocytochemical and flow cytometric detection of P-gp, MRP and LRP in childhood acute lymphoblastic leukemia.儿童急性淋巴细胞白血病中P-糖蛋白、多药耐药相关蛋白和肺耐药蛋白的最佳免疫细胞化学及流式细胞术检测

Leukemia. 1997 Jul;11(7):1078-85. doi: 10.1038/sj.leu.2400729.

Localisation of breast cancer resistance protein in microvessel endothelium of human brain.乳腺癌耐药蛋白在人脑微血管内皮中的定位。

Neuroreport. 2002 Nov 15;13(16):2059-63. doi: 10.1097/00001756-200211150-00014.

Monitoring of cellular resistance to cancer chemotherapy.监测细胞对癌症化疗的耐药性。

Hematol Oncol Clin North Am. 2002 Apr;16(2):357-72, vi. doi: 10.1016/s0889-8588(01)00016-8.

Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes.原型诱导剂在人肝细胞中诱导细胞色素P450（CYP）1A1、CYP1A2和CYP3A4的产生，但不诱导CYP2C9、CYP2C19、多药耐药性（MDR-1）和多药耐药相关蛋白（MRP-1）的产生。

Biochem Biophys Res Commun. 2000 Jun 24;273(1):333-41. doi: 10.1006/bbrc.2000.2902.

Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma.用于预测晚期卵巢癌化疗反应和预后的耐药相关标志物Lrp

J Natl Cancer Inst. 1995 Aug 16;87(16):1230-7. doi: 10.1093/jnci/87.16.1230.

Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.乳腺癌耐药蛋白/多药耐药相关蛋白、多药耐药相关蛋白1和多药耐药蛋白1/ P-糖蛋白对非典型和经典多药耐药癌细胞耐热变体的影响。

Int J Cancer. 2002 Feb 20;97(6):751-60. doi: 10.1002/ijc.10131.

Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry.通过流式细胞术对肿瘤细胞中MDR1/P170和MRP/P190介导的多药耐药性进行功能检测。

Br J Cancer. 1995 Sep;72(3):543-9. doi: 10.1038/bjc.1995.371.

引用本文的文献

In Vitro Drug Repurposing: Focus on Vasodilators.体外药物重定位：以血管扩张剂为例。

Cells. 2023 Feb 20;12(4):671. doi: 10.3390/cells12040671.

Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small cell lung cancer cells.鉴定和验证 NOLC1 作为提高多药耐药非小细胞肺癌细胞敏感性的潜在靶点。

Cell Mol Biol Lett. 2018 Nov 27;23:54. doi: 10.1186/s11658-018-0119-8. eCollection 2018.

Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells.维拉帕米抑制化疗耐药胰腺癌侧群细胞的肿瘤进展。

Int J Oncol. 2016 Jul;49(1):99-110. doi: 10.3892/ijo.2016.3512. Epub 2016 May 10.

Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance.靶向调控癌症干细胞和 EMT 的 miRNA：克服药物耐药性的新策略。

Drug Resist Updat. 2010 Aug-Oct;13(4-5):109-18. doi: 10.1016/j.drup.2010.07.001. Epub 2010 Aug 9.

Flow cytometric evaluation of multidrug resistance proteins.多药耐药蛋白的流式细胞术评估

Methods Mol Biol. 2010;596:123-39. doi: 10.1007/978-1-60761-416-6_7.

Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs.成纤维细胞生长因子：一种对抗癌药物产生广谱抗性的表观遗传机制。

Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8658-63. doi: 10.1073/pnas.140210697.

Diagnostics of multidrug resistance in cancer.癌症多药耐药性的诊断

Pathol Oncol Res. 1998;4(4):251-7. doi: 10.1007/BF02905214.

Immunohistochemical detection of DNA topoisomerase IIalpha, P-glycoprotein and multidrug resistance protein (MRP) in small-cell and non-small-cell lung cancer.免疫组织化学法检测小细胞肺癌和非小细胞肺癌中的DNA拓扑异构酶IIα、P-糖蛋白及多药耐药蛋白（MRP）

Br J Cancer. 1998 May;77(9):1469-73. doi: 10.1038/bjc.1998.241.

Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer.右维拉帕米与表柔比星治疗转移性乳腺癌无效患者的II期试验

Br J Cancer. 1998 Apr;77(7):1155-63. doi: 10.1038/bjc.1998.192.

Role of glutathione, glutathione S-transferases and multidrug resistance-related proteins in cisplatin sensitivity of head and neck cancer cell lines.谷胱甘肽、谷胱甘肽S-转移酶及多药耐药相关蛋白在头颈部癌细胞系顺铂敏感性中的作用

Br J Cancer. 1998 Feb;77(4):556-61. doi: 10.1038/bjc.1998.90.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验